Figure 1
Figure 1. Overall survival of 187 patients with PMF (median survival = 55 months; 2-year mortality = 28%) stratified by the presence or absence of SRSF2 mutations.

Overall survival of 187 patients with PMF (median survival = 55 months; 2-year mortality = 28%) stratified by the presence or absence of SRSF2 mutations.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal